Carotid artery stenting (CAS) is an option for carotid restenosis (CR) treatment with favorable outcomes. However, CAS has also emerged as an alternative to carotid endarterectomy (CEA) for the management of patients with primary carotid stenosis. This study aimed to report CR rates after CAS was performed in patients with primary lesions versus restenosis after CEA, to identify predictors of CR, and to report both neurological and overall outcomes.
Materials and methods:
From January 2000 to September 2018, a total of 782 patients were divided into 2 groups: The CAS (prim) group consisted of 440 patients in whom CAS was performed for primary lesions, and the CAS (res) group consisted of 342 patients with CAS due to restenosis after CEA. Indications for CAS were symptomatic stenosis/restenosis >70% and asymptomatic stenosis/restenosis >85%. A color duplex scan (CDS) of carotid arteries was performed 6 months after CAS, after 1 year, and annually afterward. Follow-up ranged from 12 to 88 months, with a mean follow-up of 34.6±18.0 months.
Results:
There were no differences in terms of CR rate between the patients in the CAS (prim) and CAS (res) groups (8.7% vs 7.2%, χ2=0.691, p=0.406). The overall CR rate was 7.9%, whereas significant CR (>70%) rate needing re-intervention was 5.6%, but there was no difference between patients in the CAS (prim) and CAS (res) groups (6.4% vs 4.7%, p=0.351). Six independent predictors for CR were smoking, associated previous myocardial infarction and angina pectoris, plaque morphology, spasm after CAS, the use of FilterWire or Spider Fx cerebral protection devices, and time after stenting. A carotid restenosis risk index (CRRI) was created based on these predictors and ranged from –7 (minimal risk) to +10 (maximum risk); patients with a score >–4 were at increased risk for CR. There were no differences in terms of neurological and overall morbidity and mortality between the 2 groups.
Conclusions:
There was no difference in CR rate after CAS between the patients with primary stenosis and restenosis after CEA. A CRRI score >–4 is a criterion for identifying high-risk patients for post-CAS CR that should be tested in future randomized trials.
North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade carotid stenosis. N Engl J Med. 1991;325(7):445–453.
2.
European Carotid Surgery Trialists’ Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351(9113):1379–1387.
3.
WalkerMDMarlerJRGoldsteinM, et al. Executive committee for the asymptomatic carotid atherosclerosis study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273(18):1421–1428.
4.
AbbottALParaskevasKIKakkosSK, et al. Systematic review of guidelines for the management of asymptomatic and symptomatic carotid stenosis. Stroke. 2015;46(11):3288–3301.
5.
FrericksHKievitJvan BaalenJM, et al. Carotid recurrent stenosis and risk of ipsilateral stroke: a systematic review of the literature. Stroke. 1998;29(1):244–250.
6.
TrisalVPaulsonTHansSS, et al. Carotid artery restenosis: an ongoing disease process. Am Surg. 2002;68(3):275–279.
7.
Reina-GutiérrezTSerrano-HernandoFJSánchez-HervásL, et al. Recurrent carotid artery stenosis following endarterectomy: natural history and risk factors. Eur J Vasc Endovasc Surg. 2005;29(4):334–341.
8.
LiapisCDKakisisJDKostakisAG.Recurrent carotid artery stenosis: natural history and predisposing factors. Int Angiol. 2001;20(4):330–336.
9.
TanaskovicSIsenovicERRadakD.Inflammation as a marker for the prediction of internal carotid artery restenosis following eversion endarterectomy-evidence from clinical studies. Angiology. 2011;62(7):535–542.
10.
TanaskovicSRadakDAleksicN, et al. Scoring system to predict early carotid restenosis after eversion endarterectomy by analysis of inflammatory markers. J Vasc Surg. 2018;68(1):118–127.
11.
CounsellAGhoshJMcCollumCC, et al. Carotid stenting for restenosis after endarterectomy. Cardiovasc Interv Radiol. 2011;34:488–492.
12.
KadkhodayanYMoranCJDerdeynCP, et al. Carotid angioplasty and stent placement for restenosis after endarterectomy. Neuroradiology. 2007;49(4):357–364.
13.
RadakDTanaskovicSSagicD, et al. Carotid angioplasty and stenting is safe and effective for treatment of recurrent stenosis after eversion endarterectomy. J Vasc Surg. 2014;60(3):645–651.
14.
YadavJSWholeyMHKuntzRE, et al; Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351(15):1493–1501.
15.
MasJLArquizanCCalvetD, et al. Long-term follow-up study of endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis trial. Stroke. 2014;45(9):2750–2756.
16.
EcksteinHHRinglebPAllenbergJR, et al. Results of the Stent Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol. 2008;7(10):893–902.
17.
BonatiLHDobsonJFeatherstoneRL, et al. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial. Lancet. 2015;385:529–538.
18.
BonatiLHGregsonJDobsonJ, et al. Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial. Lancet Neurol. 2018;17(7):587–596.
19.
ManteseVATimaranCHChiuD, et al. The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): stenting versus carotid endarterectomy for carotid disease. Stroke. 2010;41(Suppl 10):S31–S34.
20.
Zapata-ArriazaEMonicheFGonzálezA, et al. Predictors of restenosis following carotid angioplasty and stenting. Stroke. 2016;47(8):2144–2147.
21.
ShenHDaiZWangM, et al. Preprocedural neutrophil to albumin ratio predicts in-stent restenosis following carotid angioplasty and stenting. J Stroke Cerebrovasc Dis. 2019;28(9):2442–2447.
22.
LalBKBeachKWRoubinGS, et al. Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomized controlled trial. Lancet Neurol. 2012;11:755–763.
23.
MousaAYAbuRahmaAFBozzayJ, et al. Long-term comparative outcomes of carotid artery stenting following previous carotid endarterectomy vs de novo lesions. J Endovasc Ther. 2015;22(3):449–456.
24.
FokkemaMVrijenhoekJEDen RuijterHM, et al. Stenting versus endarterectomy for restenosis following prior ipsilateral carotid endarterectomy: an individual patient data meta-analysis. Ann Surg. 2015;261(3):598–604.
25.
KhanMALiuMWChioFL, et al. Predictors of restenosis after successful carotid artery stenting. Am J Cardiol. 2003;92(7):895–897.
26.
CosottiniMMichelassiMCBencivelliW, et al. In stent restenosis predictors after carotid artery stenting. Stroke Res Treat. 2010;2010:864724.
27.
Dakour-AridiHMathlouthiALochamS, et al. Predictors of midterm high-grade restenosis after carotid revascularization in a multicenter national database. J Vasc Surg. 2020;71(6):1972–1981.
28.
JausseranJMBergeronPReggiM, et al. Single staged carotid and coronary arteries surgery: indications and results. J Cardiovasc Surg. 1989;30(3):407–413.
29.
Al-MubarakNRoubinGSLiuMW, et al. Early results of percutaneous intervention for severe coexisting carotid and coronary artery disease. Am J Cardiol. 1999;84(5):600–602.
30.
HofmannRKerschnerKKyptaA, et al. Simultaneous stenting of the carotid artery and other coronary or extracoronary arteries: does a combined procedure increase the risk of interventional therapy. Catheter Cardiovasc Interv. 2003;60(3):314–319.
31.
KieszRSRozekMMBouknightD.Bilateral carotid stenting combined with three-vessel percutaneous coronary intervention in single setting. Catheter Cardiovasc Interv. 2001;52(1):100–105.
32.
PetrikPVGelabertHAMooreWS, et al. Cigarette smoking accelerates carotid artery intimal hyperplasia in a dose-dependent manner. Stroke. 1995;26(8):1409–1414.
33.
BonatiLHEderleJMcCabeDJ, et al. Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial. Lancet Neurol. 2009;8:908–917.
34.
CremonesiAManettiRSetacciF, et al. Protected carotid stenting: clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke. 2003;34(8):1936–1941.
35.
VijayvergiyaROtaalPSBaggaS, et al. Symptomatic carotid vasospasm caused by a distal-protection device during stent angioplasty of the right internal carotid artery. Tex Heart Inst J. 2010;37(2):226–229.
36.
SchirmerCMHoitDAMalekAM.Iatrogenic vasospasm in carotid artery stent angioplasty with distal protection devices. Neurosurg Focus. 2008;24(2):E12.
37.
NiiKTsutsumiMMaedaH, et al. Comparison of flow impairment during carotid artery stenting using two types of eccentric filter embolic protection devices. Neurol Med Chir (Tokyo). 2016;56(12):759–765.
38.
IkoMAikawaHGoY, et al. Treatment outcomes of carotid artery stenting with two types of distal protection filter device. Springerplus. 2014;3:132.
39.
KimHJLeeCSKimJS, et al. Outcomes after endovascular treatment of symptomatic patients with Takayasu’s arteritis. Interv Neuroradiol. 2011;17(2):252–260.
40.
SaadounDLambertMMiraultT, et al. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience. Circulation. 2012;125(6):813–819.
41.
de VriesEEMeershoekAJAVonkenEJ, et al. A meta-analysis of the effect of stent design on clinical and radiologic outcomes of carotid artery stenting. J Vasc Surg. 2019;69(6):1952–1961.
42.
HuangHWuLGuoY, et al. Treatment of the carotid in-stent restenosis: a systematic review. Front Neurol. 2021;12:748304.
43.
ChaturvediSYadavJS.The role of antiplatelet therapy in carotid stenting for ischemic stroke prevention. Stroke. 2006;37(6):1572–1577.
44.
MiyazakiYMoriTIwataT, et al. Continuous daily use of cilostazol prevents in-stent restenosis following carotid artery stenting: serial angiographic investigation of 229 lesions. J Neurointerv Surg. 2016;8(5):471–475.
45.
VerziniFDe RangoPParlaniG, et al. Effects of statins on early and late results of carotid stenting. J Vasc Surg. 2011;53(1):71–79.
46.
AbuRahmaAFAbu-HalimahSBensenhaverJ, et al. Primary carotid artery stenting versus carotid artery stenting for postcarotid endarterectomy stenosis. J Vasc Surg. 2009;50(5):1031–1039.
